Strong Buy Biotech Stocks Apr 2026

These stocks have received specific "Strong Buy" ratings or upgrades from major financial institutions in late April 2026:

Several biotechnology companies have recently earned ratings from analysts as of April 28, 2026. These ratings are often driven by positive clinical trial progress, strategic acquisitions, or analyst upgrades following strong performance. Latest Analyst "Strong Buy" Upgrades strong buy biotech stocks

According to TipRanks and Yahoo Finance , the following large-cap biotech stocks currently hold a consensus rating: Gilead Sciences (GILD) Regeneron Pharmaceuticals (REGN) BioNTech (BNTX) Insmed Incorporated (INSM) IQVIA Holdings (IQV) Emerging Growth & Specialized Picks These stocks have received specific "Strong Buy" ratings

: Raised to Strong Buy by HC Wainwright . strong buy biotech stocks